Johnson & Johnson (JNJ) is Private Asset Management Inc.'s 6th Largest Position

Johnson & Johnson

The firm earned "Sell" rating on Friday, July 21 by BTIG Research. The institutional investor held 322,214 shares of the major pharmaceuticals company at the end of 2016Q4, valued at $37.12 million, up from 276,610 at the end of the previous reported quarter.

Let's have a look at some of the important valuation ratios of the Johnson & Johnson (JNJ). The investment company owned 24,071 stocks of the firms shares following purchasing an extra 1,988 shares through out the period. About 1.86M shares traded. Johnson & Johnson (NYSE:JNJ) has risen 12.54% since September 20, 2016 and is uptrending. It has underperformed by 4.16% the S&P500. Next quarter's EPS is expected be $1.73 and the next full year EPS is projected to be $7.73. Rocky Mountain Advisers Limited Com accumulated 1.4% or 2,215 shares.

More notable recent Johnson & Johnson (NYSE:JNJ) news were published by: Seekingalpha.com which released: "Johnson & Johnson's Dividend Will Continue To Chug Along, But Likely At A ..." on September 19, 2017, also Realmoney.Thestreet.com with their article: "Johnson & Johnson Is Getting Ready for Another Upside Breakout" published on September 15, 2017, Seekingalpha.com published: "Johnson & Johnson - This Is A Dividend Machine" on September 15, 2017. It has underperformed by 2.74% the S&P500. Five analysts have rated the stock with a sell rating, eight have issued a hold rating and eight have given a buy rating to the company. Therefore 38% are positive. The firm has "Buy" rating by Deutsche Bank given on Tuesday, September 29. UBS AG reaffirmed a "buy" rating and set a $148.00 price target on shares of Johnson & Johnson in a report on Thursday, August 31st. Texan Capital Management holds 1.3% or 14,599 shares in its portfolio. The rating was downgraded by Vetr on Monday, August 31 to "Strong-Buy". Stifel Nicolaus has "Buy" rating and $71 target. Also, VP Paulus Stoffels sold 102,692 shares of the firm's stock in a transaction dated Monday, July 24th.

Hospitality Properties Trust is a real estate investment trust. As per Tuesday, May 24, the company rating was initiated by Topeka Capital Markets. The New York-based Pura Vida Investments Llc has invested 2.59% in the stock. The company reported $1.83 earnings per share for the quarter, topping analysts' consensus estimates of $1.79 by $0.04. They expect $0.50 earnings per share, up 13.64% or $0.06 from last year's $0.44 per share. Johnson & Johnson had a net profit margin of 22.52% and a ROE of 26.76%. the company reported sales of $18.84 B for the period end, compared with brokerage expectations of $18.94 B. For the same quarter from the prior fiscal year, firm posted $1.74 Earnings Per Share.

Investors sentiment decreased to 0.83 in 2017 Q2. Its up 0.18, from 0.76 in 2017Q1. It increased, as 63 investors sold MO shares while 529 reduced holdings. 16 funds opened positions while 25 raised stakes. Avalon Limited reported 1.23% stake. Capwealth Advsr Ltd invested 2.92% in Johnson & Johnson (NYSE:JNJ). The fund owned 900,800 shares of the company's stock after selling 13,500 shares during the period. Finemark Bank & Trust holds 88,414 shares. Chickasaw Capital holds 0.16% or 57,876 shares in its portfolio. Johnson & Johnson comprises approximately 1.4% of Factory Mutual Insurance Co.'s portfolio, making the stock its 13th largest position. Opus Cap Grp Limited Liability Company has invested 0.18% in Altria Group Inc (NYSE:MO).

Hood River Capital Management Llc holds 3.76% of its portfolio in NuVasive, Inc. for 640,690 shares. Delta Lloyd Nv invested 1.99% of its portfolio in Johnson & Johnson (NYSE:JNJ).

Institutions own 67.64% of Johnson & Johnson (JNJ)'s shares. Colonial Advsrs invested in 105,993 shares or 3.94% of the stock. Lincluden Management reported 104,364 shares. If the published price targets set by Johnson & Johnson analysts have any power to influence the stock's share price, the highest price target set for JNJ is $150.

Ratings analysis reveals 45% of Johnson & Johnson's analysts are positive. Johnson & Johnson had 64 analyst reports since August 7, 2015 according to SRatingsIntel. On Tuesday, June 14 the stock rating was maintained by Jefferies with "Hold". Johnson & Johnson presently has an average rating of "Hold" and an average target price of $135.29. The ex-dividend date was Friday, August 25th. The rating was maintained by RBC Capital Markets on Sunday, August 27 with "Buy". The company was maintained on Tuesday, July 18 by Piper Jaffray. Morgan Stanley upped their price objective on shares of Johnson & Johnson from $135.00 to $140.00 and gave the stock an "overweight" rating in a research report on Wednesday, July 5th. Jefferies maintained the shares of PG in report on Wednesday, April 19 with "Buy" rating.

Boston Common Asset Management Llc decreased its stake in Procter And Gamble Co Com (PG) by 47.02% based on its latest 2017Q2 regulatory filing with the SEC. It also increased its holding in International Flavors&Fragranc (NYSE:IFF) by 5,765 shares in the quarter, for a total of 33,683 shares, and has risen its stake in Itau Unibanco Hldg Sa Spon Adr (NYSE:ITUB). Mastercard Incorporated (NYSE:MA) was raised too.

Related:

Comments


Other news